Tag Archives: drug

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

Supernus strikes $400M+ Adamas buyout as its top drug heads toward the patent cliff

As Supernus’ top drug inches toward the patent cliff, the central nervous system-focused drugmaker has struck an M&A deal to quickly expand its portfolio of marketed medicines.  In a $ 400 million buyout, Supernus is paying $ 8.10 per share to buy CNS drugmaker Adamas Pharmaceuticals. With the deal, Supernus gets rights to Gocovri, the first and only… Read More »

States Step Up Push to Regulate Pharmacy Drug Brokers

Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies that serve as conduits for drug manufacturers, health insurers and pharmacies. More than 100 separate bills regulating those companies, known as pharmacy benefit managers, have been introduced in 42 states this year, according to the National Academy for State Health Policy, which… Read More »

Eli Lilly hit with DOJ subpoena over New Jersey factory making COVID-19 drug

Earlier this month, Eli Lilly’s COVID-19 drug factory in New Jersey garnered unwanted headlines for quality control snafus and alleged document tampering. Now, the Department of Justice (DOJ) has stepped in to investigate.  Thursday, Lilly revealed the DOJ has issued a subpoena demanding documents relating to the site in Branchburg, New Jersey. The site produces doses of Lilly’s COVID-19 antibody… Read More »